Rosuvastatin

Breastfeeding
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Alcohol, Amiodarone, Antacids, Atazanavir, Ciprofibrate, Colchicine, Conivaptan, Coumarins, Cyclosporine, Daptomycin, Darunavir, Dronedarone, Elbasvir & Grazoprevir, Eltrombopag, Eluxadoline, Erythromycin, Ethinylestradiol, Fenofibrate, Fibrates, Fosamprenavir, Fusidic Acid, Gemfibrozil, Indinavir, Ledipasvir & Sofosbuvir, Letermovir, Lopinavir, Nelfinavir, Niacin, Niacinamide, Phenindione, Progestins, Protease inhibitors, Ritonavir, Safinamide, Saquinavir, Sofosbuvir/Velpatasvir/Voxilaprevir, Tipranavir, Trabectedin, Vitamin K antagonists, Warfarin

PREGNANCY CATEGORY: X

Our database has 50 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
ENDOCRINE/METABOLIC
GASTROINTESTINAL/HEPATIC
GENITOURINARY
HEMATOLOGIC
LOCAL
NEUROMUSCULAR/SKELETAL
RENAL
RESPIRATORY
OTHER


Visit Informa

Click on the DRUG REVIEW ARTICLE tab (above) to see a review of rosuvastatin in the Informa Healthcare journal Expert Opinion on Drug Safety. (Note that non-subscribers to the journal will only be able to see an abstract of the article.)

Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric